Tema Obesity & Cardiometabolic ETF (HRTS) currently holds 46 companies focused on GLP-1, obesity, and weight-loss. Tema ETFs CEO and Founder Maurits Pot says we're trying to build a product that goes beyond GLP-1 and around for decades, so being an early investor is really important. He speaks with Katie Greifeld and Scarlet Fu on "Bloomberg ETF IQ."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.